← back to search

Ania Skowera

University College Birmingham · GB
Area of research
Immunology · Genetics
Research interest
Research interests include Immune Cell Function and Interaction, Diabetes and associated disorders, T-cell and B-cell Immunology, and Pancreatic function and diabetes.
h-index
24
citations
2,544
works
40
NIH funding
primary concept
email

Recent publications

Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes
Journal of Clinical Investigation 2018cited by 67position: middledoi
Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity
Journal of Clinical Investigation 2016cited by 159position: middledoi
Targeted suppression of autoreactive CD8+ T-cell activation using blocking anti-CD8 antibodies
Scientific Reports 2016cited by 34position: middledoi
β-Cell–Specific CD8 T Cell Phenotype in Type 1 Diabetes Reflects Chronic Autoantigen Exposure
Diabetes 2014cited by 116position: firstdoi
Comparison of peptide–major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells
Clinical & Experimental Immunology 2014cited by 89position: middledoi
Clinical-Grade Multipotent Adult Progenitor Cells Durably Control Pathogenic T Cell Responses in Human Models of Transplantation and Autoimmunity
The Journal of Immunology 2013cited by 71position: middledoi
Effector-Memory T Cells Develop in Islets and Report Islet Pathology in Type 1 Diabetes
The Journal of Immunology 2013cited by 53position: middledoi
Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation
The Journal of Experimental Medicine 2012cited by 240position: middledoi
Structural basis for the killing of human beta cells by CD8+ T cells in type 1 diabetes
Nature Immunology 2012cited by 180position: middledoi
Circulating Preproinsulin Signal Peptide–Specific CD8 T Cells Restricted by the Susceptibility Molecule HLA-A24 Are Expanded at Onset of Type 1 Diabetes and Kill β-Cells
Diabetes 2012cited by 112position: middledoi
Peptide length determines the outcome of TCR/peptide-MHCI engagement
Blood 2012cited by 99position: middledoi
Human β-Cell Killing by Autoreactive Preproinsulin-Specific CD8 T Cells Is Predominantly Granule-Mediated With the Potency Dependent Upon T-Cell Receptor Avidity
Diabetes 2012cited by 63position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Mark Peakman · King's College London11 papers (2012–2018)Andrew K. Sewell · Cardiff University7 papers (2012–2018)Garry Dolton · Cardiff University6 papers (2012–2018)Linda Wooldridge · University of Bristol5 papers (2012–2016)David K. Cole · Immunocore (United Kingdom)5 papers (2012–2016)Robin R. Knight · Guy's Hospital5 papers (2012–2014)David A. Price · London School of Hygiene & Tropical Medicine5 papers (2012–2016)John J. Miles · University of Kansas5 papers (2012–2016)Anna Bulek · Cardiff University4 papers (2012–2016)Martin Eichmann · University of Exeter4 papers (2012–2018)Deborah Kronenberg‐Versteeg · German Center for Neurodegenerative Diseases4 papers (2012–2014)Jamie Rossjohn · University of Hong Kong4 papers (2012–2016)Guo Huang · University of South China3 papers (2012–2012)P.J. Rizkallah · Indiana University School of Medicine3 papers (2012–2016)Emma Gostick · University Hospital of Wales3 papers (2012–2016)Jake Powrie · St Thomas' Hospital2 papers (2012–2014)Johanne M. Pentier · Cardiff University2 papers (2012–2014)Mathew Clement · Cardiff University2 papers (2012–2016)Katie Tungatt · University of Minnesota, Twin Cities2 papers (2014–2018)Colin Dayan · KU Leuven2 papers (2012–2014)